Clinical trial
Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus…
NCT00003601 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003601 |
|---|---|
| Title | Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome |
| Official title | A Phase II Double-Blind Study of Topical Tretinoin With or Without Oral 4-HPR (Fenretinide) in Patients With the Dysplastic Nevus Syndrome |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | fenretinide, tretinoin |
| Enrollment | 38 |
| Start date | Feb 23, 1999 |
| Primary completion | Mar 1, 2000 |
| Completion | Mar 2, 2004 |
| First posted | Aug 26, 2004 |
| Last update posted | Jun 18, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: